The Round 3 one-time assessment was launched on June 29, 2020. Initial invitations and reminders to complete the survey were sent via email only. The Round 3 assessment included the following measures: Short Urgency-Premeditation-Perseverance-Sensation Seeking-Positive Urgency (UPPS-P) Impulsive Behavior Scale27, Intolerance of Uncertainty Scale28, Emotion Regulation Questionnaire29, Brief Self-Control Scale30, and an Exit Survey collecting additional important demographic information that became apparent over the course of the assessment period and their experience as participants in the study. This included a more detailed assessment of pre-existing and current medical and mental health information, COVID-19 high risk factors, purchasing and use of personal protection equipment (PPE), information on essential workers and healthcare professionals, additional economic impacts of COVID19, implementation of stay-at-home orders or other government-ordered measures initiated in their area, and additional assessment of experience with COVID-related dreaming.

All participants had the opportunity to complete the one-time assessments from their initial launch date until August 26th, 2020. Approximately 55% of the participants completed the first one-time assessment, and approximately 42% of participants completed the Round 2 and Round 3 assessments. Of the total sample, 37.2% (n = 564) completed at least one daily survey and all three rounds of the one-time assessments. The full timeline of the study can be found in Fig. 1.

Schematic of study timeline. IRB approval and study launch occurred on March 20, 2020. Initial enrollment in the study was open until August 5, 2020. Daily survey assessments (a mix of the Full and Short Versions) took place from March 21, 2020 - May 20, 2020. The Full Version assessments then continued 2 days/week from May 21, 2020 - June 23, 2020. The one-time assessments were then released on the following dates: Round 1 – May 19, 2020; Round 2 - June 16, 2020; Round 3 – June 29, 2020.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.